|
life exposures to infections and microbiome profiles: elucidating the link and impact on chronic diseases via a population-based study (mysero-biome)
|
01-07-202330-06-2025
|
Penyelidik Bersama
|
|
seroprevalence of strongyloides stercoralis among advanced chronic kidney disease patients
|
22-06-202321-06-2025
|
Penyelidik Bersama
|
|
discover careme global registry: real world data on patient management and quality of care
|
20-05-202119-05-2025
|
Penyelidik Bersama
|
|
the role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as an adjunctive assessment tool in lupus nephritis
|
04-04-202403-04-2025
|
Penyelidik Bersama
|
|
predictors of early remission and organ damage among systemic lupus erythematosus (sle) patients in malaysia: a multi-centre study
|
24-08-202323-02-2025
|
Penyelidik Bersama
|
|
long term renal outcome in primary membranous nephropathy: a single centre experience
|
22-02-202421-02-2025
|
Ketua Projek
|
|
elucidating the effects of glucose dialysate on oxidative stress status, blood glucose, and blood pressure regulation in haemodialysis patients
|
09-07-202008-01-2025
|
Penyelidik Bersama
|
|
pilot study on dnlite-ivd103, a novel urinary glycoproteomics as a marker of kidney disease in type 2 diabetes patients
|
24-11-202223-11-2024
|
Penyelidik Bersama
|
|
a multicentre international randomized parallel group double-blind placebo-controlled clinical trial of empagliflozin once daily to assess cardio-renal outcomes in patients with chronic kidney disease
|
13-09-201812-09-2024
|
Penyelidik Bersama
|
|
the prevalence of intradialytic hypertension and its association with global longitudinal strain assessment.
|
25-03-202124-03-2024
|
Ketua Projek
|
|
a phase 2b randomised, double-blind, placebo-controlled, multi-centre, dose-ranging study of azd5718 in participants with proteinuric chronic kidney disease
|
24-01-202123-01-2024
|
Ketua Projek
|
|
elucidating the dysbiosis of firmicutes/bacteroidetes in the gut in signaling the activation of t regulatory cells, interferon alfa (ifn-α), and interleukin 6(il-6) pathway in patients with systemic lupus erythemathosus (sle).
|
01-11-202031-10-2023
|
Ketua Projek
|
|
randomised, double-blind, placebo-controlled and parallel dose group trial to investigate efficacy and safety of multiple doses of oral bi 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetic and non-diabetic chroni
|
28-02-202227-10-2023
|
Penyelidik Bersama
|
|
work disability and employment status among advanced chronic kidney disease patients
|
09-09-202108-09-2023
|
Penyelidik Bersama
|
|
-
|
11-08-202110-08-2023
|
Ketua Projek
|
|
associations of the susceptibility gene loci of systemic lupus erythematosus (sle) with renal manifestations and their functional proteins
|
01-08-202031-07-2023
|
Penyelidik Bersama
|
|
utility of intradialytic blood culture in diagnosing catheter related bloodstream infection (crbsi)
|
01-08-202031-07-2023
|
Ketua Sub Projek
|
|
clinical features and outcomes of a muti-ethnic antiphospholipid syndrome (apls) cohort in universiti kebangsaan malaysia medical centre (ukmmc)
|
15-07-202114-07-2023
|
Penyelidik Bersama
|
|
global assessment of acute and chronic kidney disease incidence and outcomes in patients with covid 19 infection
|
25-06-202024-12-2022
|
Penyelidik Bersama
|
|
height adjusted total kidney volume (httkv) using mri and age at httkv0 in predicting decline of renal function in malaysian autosomal dominant polycystic kidney disease (adpkd) cohort
|
17-12-202016-12-2022
|
Ketua Projek
|
|
height adjusted total kidney volume (httkv) using mri and age at httkv0 in predicting decline of renal function in malaysian autosomal dominant polycystic kidney disease (adpkd) cohort.
|
17-12-202016-12-2022
|
Penyelidik Bersama
|
|
comparison of optical coherence tomography angiography parameters between diabetic chronic kidney disease and non-diabetic chronic kidney disease
|
16-01-202015-11-2022
|
Penyelidik Bersama
|
|
effect of sodium glucose co transporter 2 (sglt2) inhibition on optical coherence tomography angiography (oct-a) parameters in diabetic chronic kidney disease (ckd)
|
18-12-201917-10-2022
|
Penyelidik Bersama
|
|
the prevalence of chronic kidney disease (ckd) and its associated risk factors in people living with human immunodeficiency virus (plhiv) in ukmmc
|
15-07-202114-07-2022
|
Penyelidik Bersama
|
|
comparison of retinal optical coherence tomography angiography parameters between patients with different causes of chronic kidney diseases
|
01-10-201930-06-2022
|
Penyelidik Bersama
|
|
phase 3, randomized, open-label, active-controlled study evaluating the efficacy and safety of oral vadadustat for the maintenance treatment of anemia in subjects with non-dialysis-dependent chronic kidney disease (ndd-ckd) (pro2tect - conversion)
|
18-11-201617-12-2021
|
Ketua Projek
|
|
cost-effectiveness of cyclophosphamide and non-cyclophosphamide induction therapy for lupus nephritis in hctm
|
12-03-202011-09-2021
|
Penyelidik Bersama
|
|
work disability and employment status among end stage renal disease patients starting on dialysis
|
10-09-202009-09-2021
|
Penyelidik Bersama
|
|
caregivers burdens among patients on chronic dialysis in malaysia-a single centre study
|
23-07-202022-07-2021
|
Penyelidik Bersama
|
|
the association of retinal vessel caliber, tortuosity and macula volume changes with ckd progression in diabetics vs non-diabetics over a one year period
|
12-09-201911-03-2021
|
Penyelidik Bersama
|
|
the use of intravenous pamidronate in dialysis patients undergoing parathyroidectomy
|
09-02-201808-02-2021
|
Penyelidik Bersama
|
|
aetiological spectrum of chronic kidney disease in ukm medical centre
|
24-01-201923-01-2021
|
Penyelidik Bersama
|
|
retinal microvasculature and macular changes in patients with chronic kidney disease (ckd): a case control study
|
21-08-201920-01-2021
|
Ketua Projek
|
|
renal survival rate in lupus nephritis patients in ppukm
|
16-01-202015-01-2021
|
Ketua Projek
|
|
a study to assess the renoprotective effects of the sglt2 inhibitor dapagliflozin in non-diabetic patients with proteinuria: a randomized double blind 6-weeks cross-over trial
|
08-01-201807-01-2021
|
Penyelidik Bersama
|
|
association between disease activities with exposure to air pollution index (api) and ultraviolet (uv) index among systemic lupus erythematosus patients
|
30-05-201929-11-2020
|
Penyelidik Bersama
|
|
long term outcome of immunoglobulin a (iga) nephropathy: a single centre experience
|
27-06-201926-11-2020
|
Ketua Projek
|
|
comparing gut microbiota pattern in iga nephropathy versus healthy controls
|
01-08-201931-07-2020
|
Ketua Projek
|
|
maternal and foetal outcomes in pregnant women with underlying ckd in ukmmc
|
25-07-201924-07-2020
|
Penyelidik Bersama
|
|
short term sglt2 inhibition and its effect on fasting blood sugar, urinary glucose, sodium, uric acid, macular volume and retinal vessel morphology in non proteinuric diabetic ckd vs proteinuric diabetic ckd subjects.
|
16-08-201915-07-2020
|
Penyelidik Bersama
|
|
a randomized, double-blind, event-driven, placebo-controlled, multicenter study of the effects of canagliflozin on renal and cardiovascular outcomes in subjects with type 2 diabetes mellitus and diabetic nephropathy
|
05-04-201504-05-2020
|
Ketua Projek
|
|
an observational clinical follow up study to evaluate the long term safety of an automated peritoneal dialysis cycler (lucenxia intellis) system in patients with end stage kidney disease
|
01-01-201731-12-2019
|
Penyelidik Bersama
|
|
evaluation of trans-epidermal water loss in different stages of renal impairment
|
14-03-201913-12-2019
|
Penyelidik Bersama
|
|
the epidemiology and prognostic factors for mortality in intensive care unit patients with acute kidney injury in southeast asia
|
27-04-201726-04-2019
|
Penyelidik Bersama
|
|
a randomised, open-label, parallel group, multi-centre controlled study to evaluate the clinical performance and safety of stay safe linkr compared with stay safer in patients with end-stage kidney disease on continuous ambulatory peritoneal dialysis (cap
|
26-10-201725-03-2019
|
Penyelidik Bersama
|
|
changes in urinary monocyte chemoattractant protein-1 (umcp-1) post laparascopic bariatric surgery and its correlation with renal function in morbidly obese multiethnic population : a prospective study
|
26-01-201725-01-2019
|
Penyelidik Bersama
|
|
the efficacy of combination treatment of haemoperfusion and haemodialysis versus haemodiafiltration in removing middle molecule uraemic toxins in end stage renal disease patients
|
12-10-201711-12-2018
|
Penyelidik Bersama
|
|
evaluation of glycaemic profile, hypoglycaemia and its counter-regulatory hormone and the effect of linagliptin and liraglutide during haemodialysis in diabetic end stage renal disease : a pilot study
|
18-11-201717-11-2018
|
Penyelidik Bersama
|
|
avascular necrosis (avn) among systemic lupus erythematosus (sle) patients and the associated risk factors
|
12-10-201711-04-2018
|
Penyelidik Bersama
|
|
prevalence and factors associated with work disability among sle patients in ukmmc
|
16-03-201715-02-2018
|
Penyelidik Bersama
|
|
cognitive impairment and associated factors among patients treated for systemic lupus erythematosus
|
11-08-201610-02-2018
|
Penyelidik Bersama
|
|
pregnancy in systemic lupus erythematosus (sle) patients : factors associated with disease relapse and adverse pregnancy outcomes
|
28-07-201627-01-2018
|
Penyelidik Bersama
|
|
regulatory t cells (cd4+ cd25+ foxp3+) in lupus nephritis
|
29-12-201628-12-2017
|
Ketua Projek
|
|
a comparative study of neruo-fuzzy logic algorithm versus standard sliding scale algorithm for insulin infusion adjustment in hospitalized patients with hyperglycaemia
|
27-10-201626-10-2017
|
Penyelidik Bersama
|
|
evaluation of anti-pla2r antibody in patients with primary membranous nephropathy
|
24-11-201623-05-2017
|
Penyelidik Bersama
|
|
an exploratory study asessing the short term predictors of remission of voclosporin 23.7 mg bid in combination with standard of care in patients with active lupus nephritis
|
17-04-201516-05-2017
|
Penyelidik Bersama
|
|
a randomized, double-blind, placebo-controlled phase 2/3 study to evaluate the efficacy and safety of blisibimod administration in subject with iga nephropathy
|
01-09-201301-09-2016
|
Penyelidik Bersama
|
|
the role of clinical, psychosocial factors and glutamatergic receptor genetic polymorphisms as risk factors for depressive symptomatology among patients with systemic lupus erythematosus
|
28-02-201527-08-2016
|
Penyelidik Bersama
|
|
estimation of the glomerular filtration rate in adult kidney transplant recipients
|
03-09-201402-05-2016
|
Ketua Projek
|
|
prevalence of white coat hypertension in chronic kidney disease
|
01-11-201430-04-2016
|
Ketua Projek
|
|
to evaluate the dialysate level of ca 125 in peritoneal dialysis patients and its relationship with duration of peritoneal dialysis
|
18-02-201417-02-2016
|
Penyelidik Bersama
|
|
does correction of metabolic acidosis in chronic kidney disease patients have any beneficial effects ?
|
08-02-201407-02-2016
|
Penyelidik Bersama
|
|
dialysis patients interested in research to reduce cardiovascular morbidity and mortality registry
|
15-01-201514-01-2016
|
Penyelidik Bersama
|
|
assessment of cardiovascular risk in renal transplant recipients
|
27-04-201426-10-2015
|
Penyelidik Bersama
|
|
renin and aldosterone levels in various stages of non diabetic chronic kidney disease
|
01-06-201431-05-2015
|
Penyelidik Bersama
|
|
phase iib/iii clinical study protocol - chronic renal failure (primary glomerular disease/nephroclerosis)
|
01-08-201030-11-2014
|
Penyelidik Bersama
|
|
observational study of treatment, disease activity and flare in systemic lupus erythematosus (sle) in asia pacific
|
01-05-201231-10-2014
|
Penyelidik Bersama
|
|
april (atacicept phase ii/iii, research in lupus) sle study: a randomized, double-blind, place-controlled, multicentre prospective dose-finding phase ii/iii study with atacicept given
|
01-02-200831-01-2014
|
Penyelidik Bersama
|
|
a randomised, double-blind, placebo controlled, parallel-group, multicenter study to evaluate the efficacy and safety of two doses of ocrelizumab in patients with who or isn class iii or
|
01-02-200830-08-2013
|
Penyelidik Bersama
|
|
assessment of left ventricular hypertrophy and correlation with fluid status in patients with end stage renal disease on peritoneal dialysis
|
01-06-201230-09-2012
|
Penyelidik Bersama
|
|
pulse intravenous steroid with intravenous cyclophosphamide versus added dual filtration plasmapheresis in therapy for severe lupus nephritis
|
01-10-201131-08-2012
|
Ketua Projek
|
|
effects of the three months calcitriol supplementation of inflammatory and immune biomarkers in chronic kidney disease patients with low serum vitamin d levels
|
01-03-201130-11-2011
|
Ketua Projek
|
|
measurement of patient reported outcomes in renal transplant patients with and without gastrointestinal (gi) symptoms (progis)
|
01-11-200930-11-2011
|
Penyelidik Bersama
|
|
a randomised, double-blind, placebo controlled, parallel-group, multicenter study to evaluate the efficacy and safety of two doses of ocrelizumab in patients with active systemic lupus
|
01-02-200801-03-2011
|
Penyelidik Bersama
|
|
a phase 2/3, randomized, double-blind, placebo-controlled, multicentre study to evaluate the safety and efficacy of atacicept in subjects with lupus nephritis in combination with
|
01-02-200801-12-2010
|
Penyelidik Bersama
|
|
evaluation of chronic kidney disease practise patterns through the global renal information database (grid)
|
01-06-200931-07-2010
|
Penyelidik Bersama
|
|
the comparison between glycated albumin (ga) and glycated haemaglobin (hba1c) in assessing glicaemic control type 2 diabetes mellistus patients with chronic kidney disease (ckd) and
|
01-08-200930-07-2010
|
Penyelidik Bersama
|
|
prevalence of various risk factors for chronic kidney disease progression and their control in patients attending the nephrology clinic of ppukm
|
01-12-200831-08-2009
|
Penyelidik Bersama
|
|
tabung agihan penyelidikan (tap)-k014167
|
24-07-2021
|
Penyelia
|